Rxivist logo

A Randomised, Double-Blind, Sham-Controlled Trial of Deep Brain Stimulation of the Bed Nucleus of the Stria Terminalis for Treatment-Resistant Obsessive-Compulsive Disorder

By Philip E. Mosley, François Windels, John Morris, Terry Coyne, Rodney Marsh, Andrea Giorni, Adith Mohan, Perminder S. Sachdev, Emily O’Leary, Mark Boschen, Pankaj Sah, Peter A. Silburn

Posted 27 Oct 2020
medRxiv DOI: 10.1101/2020.10.24.20218024

1Deep brain stimulation (DBS) is a promising treatment for severe, treatment-resistant obsessive-compulsive disorder (OCD). Here, nine participants (four females, mean age 47.9 {+/-}10.7 years) were implanted with DBS electrodes bilaterally in the bed nucleus of the stria terminalis (BNST). Following a one-month postoperative recovery phase, participants entered a three-month randomised, double-blind, sham-controlled phase before a twelve-month period of open-label stimulation incorporating a course of cognitive behavioural therapy (CBT). The primary outcome measure was OCD symptoms as rated with the Yale-Brown Obsessive-Compulsive Scale (YBOCS). In the blinded phase, there was a significant benefit of active stimulation over sham (p = 0.025, mean difference 4.9 points). After the open phase, the mean reduction in YBOCS was 16.6 {+/-}1.9 points (X2 (11) = 39.8, p = 3.8 x 10-5), with seven participants classified as responders. CBT resulted in an additive YBOCS reduction of 4.8 {+/-}3.9 points (p = 0.011). There were two serious adverse events related to the DBS device, the most severe of which was an infection during the open phase necessitating device explantation. There were no psychiatric adverse events related to stimulation. An analysis of the structural connectivity of each participants individualised stimulation field isolated right-hemispheric fibres associated with YBOCS reduction. These included subcortical tracts incorporating the amygdala, hippocampus and stria terminalis, in addition to cortical regions in the ventrolateral and ventromedial prefrontal cortex, parahippocampal, parietal and extrastriate visual cortex. In conclusion, this study provides further evidence supporting the efficacy and tolerability of DBS for individuals with otherwise treatment-refractory OCD and identifies a connectivity fingerprint associated with clinical benefit.

Download data

  • Downloaded 167 times
  • Download rankings, all-time:
    • Site-wide: 113,924
    • In psychiatry and clinical psychology: 481
  • Year to date:
    • Site-wide: 42,838
  • Since beginning of last month:
    • Site-wide: 41,484

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)